OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
M&A Transactions
M&A Transaction Chart
Viridian publishes weekly data on M&A transactions in the Cannabis/CBD/Psychedelic industries. This data includes information about the buyer and seller (public/private, state/country location), deal size, deal structure (cash, stock, earn-out), pricing, share information, and deal implied valuation.
Week ended 05/19/2023
Week ended 05/19/2023
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
M&A Transactions Commentary
Week ended 05/19/2023
The Most Interesting Closed M&A Deal of the Week:
- On May 16, 2023, Creso Pharma Ltd (COPHF: OTC)(CPH: ASX), which develops and commercializes pharmaceutical-grade cannabis and hemp-based nutraceutical products in Europe, Canada, Asia Pacific, and the U.S. completed their acquisition of Health House Intl. (HHI: ASX).
- Health House is an international pharmaceutical distributor distributing medicinal cannabis products in Australia.
- The total consideration of $3.1M was composed of stock of $.84M and seller notes for $2.26M.
- The transaction implied an EV/ LTM revenues multiple of .24x
Week ended 05/19/2023
This is the MA basic
Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more.
Viridian publishes weekly insights on the M&A landscape in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful M&A transactions for that week, and commentary on market conditions, M&A deal structures, target regions for acquirers, and industry sectors ripe for consolidation.